Delivery Order SPE2DB22D3301-SPE2DB24FY6UJ
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,136.62. It is for the supply of GADAVIST 1 MMOL/ML BULK VIAL 30ML, a medical product. The contract has an ultimate completion date of May 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds...
- This federal contract award, valued at $1,942.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.51 firm fixed-price delivery order is for the supply of Gadavist 1 mmol/ml bulk vials (30 ml). The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,711.35 Delivery Order contract is for the supply of GADAVIST 1 MMOL/ML BULK VIAL 30ML, which is a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of July 10, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
- This federal contract award is for the delivery of GADAVIST 1 MMOL/ML BULK VIAL 30ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,711.35 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has a completion date of July 2, 2024 and was awarded on July 1, 2024. There was no set-aside designation used for this award. Amerisourcebergen holds a larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the U.S. The contract is a delivery order worth $1,711.35 for the supply of Gadavist 1 mmol/mL bulk vials. The contract has an ultimate completion date of September 10, 2024 and is a firm fixed-price contract. AmerisourceBergen has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies for a wide range of...
- This federal contract award to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Gadavist (15 milliliters per vial). The contract has a ceiling value of $1,389.15 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.20 firm fixed-price delivery order is for the supply of GADAVIST 10 MMOL/10 ML VIAL 10ML, a medical product. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award, valued at $9,435.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through December 2025. The contract is for the delivery of GADAVIST 10 MMOL/10 ML VIAL 10ML, a pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,274.88, for the supply of GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML. The contract has an Ultimate Completion Date of April 1, 2025 and was awarded on March 31, 2025. This award is not a set-aside contract....
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY6UJDelivery Order
This federal contract award, valued at $1,140.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GADAVIST 1 MMOL/ML BULK VIAL 30ML. The award is a delivery order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation. Amerisourcebergen, a subsidiary of the Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally, leverages its extensive supply chain network to fulfill government contracts, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/15/24 |